… : a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein …
GL Wright Jr, LH Cazares, SM Leung, S Nasim, BL … - Prostate Cancer Prostatic Dis, 1999 - nature.com
... surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel
protein biochip technology for detection of prostate cancer biomarkers in ...
… , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer -
J Li, C Yen, D Liaw, K Podsypanina, S Bose, SI … - Science, 1997 - sciencemag.org
... Reports. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain,
Breast, and Prostate Cancer. ... (C) Mutation in prostate cancer cell line LNCaP. ...
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study. -
JM Chan, MJ Stampfer, E Giovannucci, PH Gann, J Ma … - The Journal of Urology, 1998 - jurology.com
... Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study. ...
Citing Articles TOP. Obesity and prostate cancer. Current Opinion in Urology. ...
Intake of Carotenoids and Retino in Relation to Risk of Prostate Cancer -
E Giovannucci, A Ascherio, EB Rimm, MJ Stampfer, … - jnci, 1995 - jnci.oxfordjournals.org
... Intake of Carotenoids and Retino in Relation to Risk of Prostate Cancer. ... No consistent
association was observed for dietary retinol and risk of prostate cancer. ...
The Influence of Finasteride on the Development of Prostate Cancer -
IM Thompson, PJ Goodman, CM Tangen, MS Lucia, GJ … - New England Journal of Medicine, 2003 - content.nejm.org
The Influence of Finasteride on the Development of Prostate Cancer. Ian M. Thompson,
MD, Phyllis J. Goodman, MS, Catherine M. Tangen, Dr.PH, M. Scott Lucia, MD ...
… and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional … -
AW Partin, MW Kattan, EN Subong, PC Walsh, KJ … - JAMA, 1997 - Am Med Assoc
... Combination of prostate-specific antigen, clinical stage, and Gleason score
to predict pathological stage of localized prostate cancer. ...
Quality-of-life outcomes in men treated for localized prostate cancer -
MS Litwin, RD Hays, A Fink, PA Ganz, B Leake, GE … - JAMA, 1995 - Am Med Assoc
... Quality-of-life outcomes in men treated for localized prostate cancer. ... ABSTRACT |
FULL TEXT. Natural History of Early, Localized Prostate Cancer Johansson et al. ...
In vivo amplification of the androgen receptor gene and progression of human prostate cancer -
T Visakorpi, E Hyytinen, P Koivisto, M Tanner, R … - Nature Genetics, 1995 - nature.com
... In vivo amplification of the androgen receptor gene and progression of human prostate
cancer. ... Prostate cancer: therapeutics, diagnostic, and basic studies. Lab. ...
Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and … -
M Bolla, D Gonzalez, P Warde, JB Dubois, RO … - New England Journal of Medicine - content.nejm.org
... Next Next. Improved Survival in Patients with Locally Advanced Prostate Cancer Treated
with Radiotherapy and Goserelin. ... The Changing Face of Prostate Cancer. ...
… and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer -
DP Petrylak, CM Tangen, MHA Hussain, PN Lara Jr, … - New England Journal of Medicine, 2004 - content.nejm.org
... Next Next. Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone
for Advanced Refractory Prostate Cancer. ... The role of Src in prostate cancer. ...
Source: Google Scholar |